✨ Free AI Report
IceCure Medical Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research IceCure Medical Ltd.
Company Research

IceCure Medical Ltd.: Business Overview, Financials & Competitive Analysis

IceCure Medical Ltd. scores 3/10 on the AskCyborg Cyborg Score (Weak). Early-stage cryoablation innovator with proven technology but minimal market traction and significant capitalization pressure. As of March 18, 2026, IceCure's stock price was $0.6001 with a market capitalization of approximately $50.3 million. The company received Nasdaq minimum bid price non-compliance notification in July 2024, requiring shares to maintain at.

What is IceCure Medical Ltd.'s industry? IceCure Medical Ltd. (icecure-medical.com) operates in Medical Devices. AskCyborg classifies IceCure Medical Ltd. under Medical Devices in its company registry.

IceCure Medical develops and markets advanced liquid-nitrogen-based cryoablation therapy systems designed to destroy benign and cancerous tumors by freezing them as a minimally invasive option to surgical tumor remova...

3/ 10Weak

Cyborg Score thesis

Early-stage cryoablation innovator with proven technology but minimal market traction and significant capitalization...

Read the full analyst-debate transcript →
Industry Medical Devices
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest IceCure Medical Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for IceCure Medical Ltd.

AskCyborg analysts argue the bull and bear cases for IceCure Medical Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
IceCure Medical Ltd. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

IceCure Medical Ltd. Overview

Pro stress-test →

IceCure Medical develops and markets advanced liquid-nitrogen-based cryoablation therapy systems designed to destroy benign and cancerous tumors by freezing them as a minimally invasive option to surgical tumor removal. The company's primary focus areas include breast, kidney, bone, and lung cancer, and its technology is intended to be performed in relatively short procedures.

Strategic Profile

Pro stress-test →

The company's flagship product is the ProSense® Cryoablation System, described as a minimally invasive cryosurgical tool that uses liquid nitrogen to create large lethal zones for tumor destruction. The commercial-stage company markets its systems and technologies internationally, with presence in the United States, Japan, India, China, Israel, and other markets.

Competitive Landscape

Pro stress-test →

Investors comparing IceCure often look at related companies in the medical devices sector, including Pulmonx Corp (LUNG), Volitionrx (VNRX), Baird Medical (BDMD), Apyx Medical Corporation (APYX), and Tela Bio, Inc. (TELA). IceCure's cryoablation technology positions it as a niche player in minimally invasive tumor treatment, competing against both traditional surgical approaches and alternative ablation technologies.

Industry Context

IceCure Medical Ltd. operates in Medical Devices.

Key facts

Founded: 2006 · Headquarters: Caesarea, Israel · Employees: N/A · Revenue: N/A · Market cap: $50.3M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on IceCure Medical Ltd..

  • Company raised $4.0 million in a registered direct offering in March 2026, selling 8 million ordinary shares at $0.50 per share to healthcare-focused institutional investors.
  • Beyond the lead ProSense single-probe system, the company developed a MultiSense multi-probe system expected to freeze several tumors simultaneously, which has not yet been commercialized.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Raised $4.0 million through registered direct offering at $0.50 per share
  • July 2024Received Nasdaq minimum bid price non-compliance notification
  • +1 moreTrack every material event for IceCure Medical Ltd. as it happens. Explore monitoring →
Get alerted when IceCure Medical Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare IceCure Medical Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

IceCure Medical Ltd. operates in Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices research →
NEW · MCP server

Ask your AI assistant about IceCure Medical Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare IceCure Medical Ltd. and its top competitor on Cyborg Score”
“What did IceCure Medical Ltd. do this quarter?”
“Is IceCure Medical Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does IceCure Medical Ltd. do?+
IceCure Medical develops and markets advanced liquid-nitrogen-based cryoablation therapy systems designed to destroy benign and cancerous tumors by freezing them as a minimally invasive option to surgical tumor remova...
What is IceCure Medical Ltd.'s Cyborg Score?+
IceCure Medical Ltd. has a Cyborg Score of 3/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are IceCure Medical Ltd.'s main competitors?+
Named competitors include Pulmonx, Apyx, Baird Medical. The full competitive landscape is in the AskCyborg report.
How can I get the full IceCure Medical Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the IceCure Medical Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track IceCure Medical Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual